Global Extracorporeal Membrane Oxygenation Machine Market Outlook to 2028

Global ECMO Machine Market Overview

The global ECMO (Extracorporeal Membrane Oxygenation) machine market was valued at USD 587 million in 2023, driven by increasing cases of respiratory and cardiac failure, rising awareness of advanced life support technologies, and the growing adoption of ECMO in critical care. The market is segmented into veno-arterial ECMO, veno-venous ECMO, and hybrid ECMO, with veno-venous ECMO being the most dominant due to its effectiveness in treating respiratory failure.

Major players in the global ECMO machine market include Getinge AB, Medtronic, Liva Nova, Terumo Corporation, and Xenios AG. These companies are recognized for their extensive product portfolios, research-driven innovations, and strategic alliances with healthcare institutions. Getinge AB leads the market with its highly advanced ECMO systems known for their ease of use and cutting-edge technology.

The U.S., Germany, and Japan are prominent markets, driven by high healthcare expenditure and the increasing adoption of ECMO technology in advanced life support. These countries are characterized by a mature healthcare infrastructure with investments in critical care technologies.

In 2023, Liva Nova launched a new compact and portable ECMO machine, aimed at increasing ECMO accessibility in smaller hospitals and emergency settings. This innovation reflects the ongoing shift toward more mobile and user-friendly ECMO solutions in response to the global rise in demand for ECMO treatments.

Global ECMO Machine Market Segmentation

The Global ECMO Machine Market can be segmented by product application, and region:

By Application: The market is segmented into respiratory, cardiac, and neonatal/pediatric care. Respiratory care dominates the market, accounting for the largest share due to the rise in respiratory diseases and the growing use of ECMO for COVID-19 patients. Cardiac care is expected to see remarkable growth due to the increasing prevalence of cardiovascular diseases globally.

By Region: The market is regionally segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In 2023, North America leads the market due to high healthcare spending, technological advancements, and the growing number of ECMO centers. Asia-Pacific is expected to witness the highest growth rate due to the increasing investments in healthcare infrastructure and rising awareness of ECMO technology.

By Product Type: The market is segmented into veno-arterial ECMO, veno-venous ECMO, and hybrid ECMO. In 2023, veno-venous ECMO remains the most dominant segment due to its effectiveness in supporting patients with severe respiratory failure. Veno-arterial ECMO is gaining traction in cardiac failure cases, while hybrid ECMO is emerging as a solution for complex conditions.

Global ECMO Machine Market Competitive Landscape

Company

Establishment Year

Headquarters

Getinge AB

1904

Gothenburg, Sweden

Medtronic

1949

Dublin, Ireland

Liva Nova

2015

London, UK

Terumo

1921

Tokyo, Japan

Xenios AG

2013

Heilbronn, Germany

Getinge AB: In 2023, Getinge launched a new ECMO system with improved monitoring capabilities and a streamlined design to enhance patient outcomes in critical care units. The system has gained attention in the U.S. and European markets, further solidifying Getinges market position.

Medtronic: In 2024, Medtronic expanded its ECMO product line by introducing a hybrid system that supports both respiratory and cardiac failure. This product innovation aligns with the growing demand for flexible and multi-functional ECMO systems, especially in rapidly evolving healthcare environments.

Global ECMO Machine Market Analysis

Market Growth Drivers:

Increasing Prevalence of Respiratory Diseases: The global rise in respiratory diseases, such as COPD and ARDS, is contributing to higher demand for ECMO machines. The WHO reports that respiratory diseases account for over 4 million deaths annually, driving the need for advanced life support technologies.

Growing Number of ECMO Centers: The number of ECMO centers globally has expanded, with over 500 certified ECMO centers operating worldwide. The U.S. leads with more than 150 centers, followed by Europe with around 120 centers, indicating growing adoption in critical care facilities.

Rising Use in Cardiac and Neonatal Care: The increasing application of ECMO in neonatal care is evident, with more than 8,000 neonates treated globally using ECMO technology each year. Additionally, cardiac care procedures utilizing ECMO have grown, with over 15,000 cardiac patients supported annually in the U.S. alone.

Market Challenges
:

Shortage of Trained Professionals: ECMO procedures require highly skilled healthcare professionals, including specialized nurses and perfusionists. Globally, there are fewer than 1,000 certified ECMO specialists, creating a gap between demand and available expertise, especially in developing countries.

High Initial Investment Costs: The cost of setting up an ECMO unit is substantial, with a typical ECMO system costing between 100,000 to 300,000 USD. Additionally, maintenance and operational costs, including disposables, can exceed 5,000 USD per procedure, making ECMO a financially challenging option for smaller hospitals.

Government Initiatives:

Chinas Healthcare Expansion Plan for ECMO: The Chinese government, under its 14th Five-Year Healthcare Plan, has dedicated 12 billion CNY for the deployment and maintenance of ECMO systems in over 600 hospitals by 2026. This initiative is a direct response to the lessons learned from the COVID-19 pandemic, where ECMO played a critical role in life support for severe respiratory failure. The plan includes training programs for medical staff and partnerships with leading ECMO manufacturers to ensure cutting-edge technology in critical care.

Germanys National ECMO Strategy: Germanys federal government has allocated 40 million EUR in 2023 to enhance ECMO capabilities across major hospitals, with the goal of installing additional machines and upgrading existing systems by 2026. The investment includes funding for ECMO training programs for healthcare professionals and R&D grants aimed at improving ECMOs operational safety and reducing complications. This initiative is a core part of Germany's effort to bolster its critical care infrastructure and prepare for future public health emergencies.

Global ECMO Machine Market Future Outlook

The global ECMO machine market is expected to witness substantial growth, driven by the increasing adoption of advanced life support technologies and the rising prevalence of respiratory and cardiac disorders.

Future Market Trends:

Portable ECMO Devices: The trend toward developing compact, portable ECMO devices is expected to continue, with innovations aimed at enhancing ECMO accessibility in emergency and remote care settings.

Focus on Automation: Automation in ECMO systems, with features such as AI-driven monitoring and adjustments, will likely gain prominence, reducing the need for highly specialized personnel and minimizing human error in critical care scenarios.
Please Note: It will take 5-7 business days to complete the report upon order confirmation